Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery



Status:Active, not recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 85
Updated:2/3/2019
Start Date:June 2013
End Date:March 2019

Use our guide to learn which trials are right for you!

Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery

The investigator goal is to evaluate the effects of intraoperative and postoperative
dexmedetomidine sedation (versus placebo after cardiac surgery.

Inclusion Criteria:

1. 18-85 years old;

2. Scheduled for cardiac surgery with bypass (CABG, valve, or combined);

3. Able to provide a written informed consent;

4. Hemodynamically stable (heart rate>= 55).

Exclusion Criteria:

1. Sick sinus syndrome or Wolff-Parkinson-White syndrome

2. Atrio-ventricular block

3. Hypersensitivity or known allergy to dexmedetomidine

4. Hepatic disease, e.g. twice the normal level of liver enzymes

5. AF within 1 preoperative month;

6. Permanent pacemaker;

7. Use of amiodarone or dexmedetomidine within the last 30 days;

8. Patients with an ejection fraction under 30% or who had severe heart failure

9. Myocardial infarction in the previ¬ous 7 days;

10. Body mass index =< 40 (BMI= mass (kg) / height (m)2);

11. Those tak¬ing clonidine within last 48 hours.
We found this trial at
1
site
Cleveland, Ohio 44195
Principal Investigator: Alparslan Turan, MD
Phone: 216-444-9950
?
mi
from
Cleveland, OH
Click here to add this to my saved trials